Yüklüyor......
Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML
Acute myeloid leukaemia (AML) carrying internal tandem duplication (ITD) of Fms-Like Tyrosine kinase 3 (FLT3) gene is associated with high risk of relapse and poor clinical outcome upon treatment with conventional chemotherapy. FLT3 inhibitors have been approved for the treatment of this AML subtype...
Kaydedildi:
| Yayımlandı: | Int J Mol Sci |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7073218/ https://ncbi.nlm.nih.gov/pubmed/32102366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21041537 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|